Factors determining the stability, size distribution, and cellular accumulation of small, monodisperse chitosan nanoparticles as candidate vectors for anticancer drug delivery: application to the passive encapsulation of [14C]-doxorubicin [Corrigendum]

Masarudin MJ, Cutts SM, Evison BJ et al. Nanotechnol Sci Appl. 2015;8:67–80The authors advise that Professor Geoffrey A Pietersz was erroneously omitted from the original author and affiliation list, the list should have been:Mas Jaffri Masarudin1Suzanne M Cutts2Geoffrey A Pietersz3Benny J...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Masarudin MJ, Cutts SM, Pietersz GA, Evison BJ, Phillips DR, Pigram PJ
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2016
Materias:	Medical technology R855-855.5 Chemical technology TP1-1185
Acceso en línea:	https://doaj.org/article/595219ef206e4ae8917762572a32b858
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:595219ef206e4ae8917762572a32b858
record_format	dspace
spelling	oai:doaj.org-article:595219ef206e4ae8917762572a32b8582021-12-02T06:50:10ZFactors determining the stability, size distribution, and cellular accumulation of small, monodisperse chitosan nanoparticles as candidate vectors for anticancer drug delivery: application to the passive encapsulation of [14C]-doxorubicin [Corrigendum]1177-8903https://doaj.org/article/595219ef206e4ae8917762572a32b8582016-08-01T00:00:00Zhttps://www.dovepress.com/corrigendum-factors-determining-the-stability-size-distribution-a-peer-reviewed-article-NSAhttps://doaj.org/toc/1177-8903Masarudin MJ, Cutts SM, Evison BJ et al. Nanotechnol Sci Appl. 2015;8:67–80The authors advise that Professor Geoffrey A Pietersz was erroneously omitted from the original author and affiliation list, the list should have been:Mas Jaffri Masarudin1Suzanne M Cutts2Geoffrey A Pietersz3Benny J Evison4Don R Phillips2Paul J Pigram51Department of Cell and Molecular Biology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, Serdang, Malaysia; 2Department of Biochemistry, La Trobe University, Melbourne, Victoria, Australia; 3Bioorganic and Medicinal Chemistry Laboratory, Centre for Biomedical Research, Burnet Institute, Melbourne, Victoria, Australia; 4Department of Chemical Biology and Therapeutics, St Jude Children’s Hospital, Memphis, TN, USA; 5Department of Physics, La Trobe University, Melbourne, Victoria, AustraliaThe Acknowledgment section should have contained the statement: This work was also supported by a research grant from Cancer Council Victoria.Read the original articleMasarudin MJCutts SMPietersz GAEvison BJPhillips DRPigram PJDove Medical PressarticleMedical technologyR855-855.5Chemical technologyTP1-1185ENNanotechnology, Science and Applications, Vol 2016, Iss Issue 1, Pp 47-48 (2016)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medical technology R855-855.5 Chemical technology TP1-1185
spellingShingle	Medical technology R855-855.5 Chemical technology TP1-1185 Masarudin MJ Cutts SM Pietersz GA Evison BJ Phillips DR Pigram PJ Factors determining the stability, size distribution, and cellular accumulation of small, monodisperse chitosan nanoparticles as candidate vectors for anticancer drug delivery: application to the passive encapsulation of [14C]-doxorubicin [Corrigendum]
description	Masarudin MJ, Cutts SM, Evison BJ et al. Nanotechnol Sci Appl. 2015;8:67–80The authors advise that Professor Geoffrey A Pietersz was erroneously omitted from the original author and affiliation list, the list should have been:Mas Jaffri Masarudin1Suzanne M Cutts2Geoffrey A Pietersz3Benny J Evison4Don R Phillips2Paul J Pigram51Department of Cell and Molecular Biology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, Serdang, Malaysia; 2Department of Biochemistry, La Trobe University, Melbourne, Victoria, Australia; 3Bioorganic and Medicinal Chemistry Laboratory, Centre for Biomedical Research, Burnet Institute, Melbourne, Victoria, Australia; 4Department of Chemical Biology and Therapeutics, St Jude Children’s Hospital, Memphis, TN, USA; 5Department of Physics, La Trobe University, Melbourne, Victoria, AustraliaThe Acknowledgment section should have contained the statement: This work was also supported by a research grant from Cancer Council Victoria.Read the original article
format	article
author	Masarudin MJ Cutts SM Pietersz GA Evison BJ Phillips DR Pigram PJ
author_facet	Masarudin MJ Cutts SM Pietersz GA Evison BJ Phillips DR Pigram PJ
author_sort	Masarudin MJ
title	Factors determining the stability, size distribution, and cellular accumulation of small, monodisperse chitosan nanoparticles as candidate vectors for anticancer drug delivery: application to the passive encapsulation of [14C]-doxorubicin [Corrigendum]
title_short	Factors determining the stability, size distribution, and cellular accumulation of small, monodisperse chitosan nanoparticles as candidate vectors for anticancer drug delivery: application to the passive encapsulation of [14C]-doxorubicin [Corrigendum]
title_full	Factors determining the stability, size distribution, and cellular accumulation of small, monodisperse chitosan nanoparticles as candidate vectors for anticancer drug delivery: application to the passive encapsulation of [14C]-doxorubicin [Corrigendum]
title_fullStr	Factors determining the stability, size distribution, and cellular accumulation of small, monodisperse chitosan nanoparticles as candidate vectors for anticancer drug delivery: application to the passive encapsulation of [14C]-doxorubicin [Corrigendum]
title_full_unstemmed	Factors determining the stability, size distribution, and cellular accumulation of small, monodisperse chitosan nanoparticles as candidate vectors for anticancer drug delivery: application to the passive encapsulation of [14C]-doxorubicin [Corrigendum]
title_sort	factors determining the stability, size distribution, and cellular accumulation of small, monodisperse chitosan nanoparticles as candidate vectors for anticancer drug delivery: application to the passive encapsulation of [14c]-doxorubicin [corrigendum]
publisher	Dove Medical Press
publishDate	2016
url	https://doaj.org/article/595219ef206e4ae8917762572a32b858
work_keys_str_mv	AT masarudinmj factorsdeterminingthestabilitysizedistributionandcellularaccumulationofsmallmonodispersechitosannanoparticlesascandidatevectorsforanticancerdrugdeliveryapplicationtothepassiveencapsulationof14cdoxorubicincorrigendum AT cuttssm factorsdeterminingthestabilitysizedistributionandcellularaccumulationofsmallmonodispersechitosannanoparticlesascandidatevectorsforanticancerdrugdeliveryapplicationtothepassiveencapsulationof14cdoxorubicincorrigendum AT pieterszga factorsdeterminingthestabilitysizedistributionandcellularaccumulationofsmallmonodispersechitosannanoparticlesascandidatevectorsforanticancerdrugdeliveryapplicationtothepassiveencapsulationof14cdoxorubicincorrigendum AT evisonbj factorsdeterminingthestabilitysizedistributionandcellularaccumulationofsmallmonodispersechitosannanoparticlesascandidatevectorsforanticancerdrugdeliveryapplicationtothepassiveencapsulationof14cdoxorubicincorrigendum AT phillipsdr factorsdeterminingthestabilitysizedistributionandcellularaccumulationofsmallmonodispersechitosannanoparticlesascandidatevectorsforanticancerdrugdeliveryapplicationtothepassiveencapsulationof14cdoxorubicincorrigendum AT pigrampj factorsdeterminingthestabilitysizedistributionandcellularaccumulationofsmallmonodispersechitosannanoparticlesascandidatevectorsforanticancerdrugdeliveryapplicationtothepassiveencapsulationof14cdoxorubicincorrigendum
_version_	1718399691901632512

Factors determining the stability, size distribution, and cellular accumulation of small, monodisperse chitosan nanoparticles as candidate vectors for anticancer drug delivery: application to the passive encapsulation of [14C]-doxorubicin [Corrigendum]

Ejemplares similares